Total Clarity Wealth Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8	Closed	–	–	171
2019 Q4	$0	Buy	+8	New	–	﹤0.01%	685